Myelodysplastic syndrome patients
| Number . | Sex . | Race . | Age . | Initial BM diagnosis MDS . | Review BM diagnosis MDS . | Flow bilineage or trilineage dysplasia . | Cytogenetics clonal abnormality . | Final diagnosis . | Erythroid . | Megakaryocytic . | Myeloid . | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | |||||||||
| 1 | F | H | 34 | − | + | + | NE | RA | − (NE) | + | + | − | NE | + |
| 2 | F | W | 70 | + | + | + | + | RA | + | − | + | + | + | + |
| 3 | M | W | 60 | + | + | + | − | RA | + | + | + | − | + | + |
| 4 | M | B | 32 | − | + | + | − | RA | + | + | + | + | + | + |
| 5 | M | W | 65 | + | + | + | − | RA | + | + | + | − | − | + |
| 6 | F | W | 72 | − | + | + | + | RA | − | − | + | + | + | + |
| 7 | F | W | 46 | − | + | − | − | RA | + | − | + | − | + | + |
| 8 | M | W | 27 | + | + | + | NE | RA | + | + | + | + | + | + |
| 9 | F | A | 58 | + | + | NE | − | RA | + | + | + | − | + | NE |
| 10 | F | W | 62 | + | + | + | − | RA | + | + | − | − | + | + |
| 11 | M | A | 77 | − | + | + | + | RA | + | + | + | + | + | NE |
| 12 | M | W | 76 | + | + | + | − | RA | + | + | + | − | + | + |
| 13 | M | B | 61 | + | + | + | + | RA | + | + | + | − | + | + |
| 14 | F | W | 67 | + | + | + | + | RA | + | + | + | + | − | + |
| 15 | F | W | 49 | + | + | + | + | RA | − | + | + | + | + | + |
| 16 | M | W | 60 | − | + | + | + | RA | NE | + | + | + | − | + |
| 17 | M | W | 69 | + | + | + | − | RA | + | + | + | + | + | + |
| 18 | M | W | 47 | − | + | − | NE | RA | + | − | + | − | − | + |
| 19 | F | W | 37 | − | + | + | − | RA | + | + | + | NE | + | + |
| 20 | F | W | 43 | + | + | + | − | RA | − | + | + | + | + | + |
| 21 | M | W | 45 | + | + | − | − | RA | + | − | + | − | + | + |
| 22 | M | W | 56 | + | + | + | − | RA | − | + | + | + | + | + |
| 23 | M | W | 57 | + | + | + | − | RARS | + | + | + | + | + | + |
| 24 | M | W | 68 | + | + | + | NE | RARS | + | + | + | + | + | + |
| 25 | M | W | 72 | + | + | + | + | RARS | + | + | + | + | + | + |
| 26 | M | W | 60 | + | + | + | + | RARS | + | + | − | + | − | + |
| 27 | F | W | 66 | + | + | + | + | RARS | + | + | + | − | + | + |
| 28 | F | W | 44 | − | + | + | − | RARS | + | + | + | + | + | − |
| 29 | F | W | 67 | + | + | + | + | RARS | + | + | − | + | + | + |
| 30 | M | W | 61 | − | + | − | NE | RARS | + | − | + | − | NE | + |
| 31 | M | W | 67 | + | + | + | − | RARS | + | − | + | + | − | + |
| 32 | M | W | 69 | + | + | + | + | RARS | + | − | + | + | − | + |
| 33 | M | W | 63 | + | + | + | + | RAEB | − | + | + | + | + | + |
| 34 | M | W | 64 | − | + | NE | NE | RAEB | − | NE | − | − | + | + |
| 35 | F | W | 69 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 36 | F | W | 61 | + | + | + | − | RAEB | + | + | + | − | + | + |
| 37 | M | W | 65 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 38 | M | W | 58 | + | + | + | + | RAEB | + | + | + | − | + | + |
| 39 | M | W | 51 | − | + | − | − | RAEB | + | − | + | − | − | + |
| 40 | M | W | 81 | + | + | + | + | RAEB | + | + | + | + | + | NE |
| 41 | M | W | 71 | + | + | + | − | RAEB | − | − | + | + | + | + |
| 42 | F | W | 61 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 43 | M | W | 72 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 44 | M | W | 64 | + | + | + | − | RAEB | + | + | + | − | + | + |
| 45 | F | W | 63 | + | + | + | + | RAEB-T | + | + | + | − | + | + |
| Number . | Sex . | Race . | Age . | Initial BM diagnosis MDS . | Review BM diagnosis MDS . | Flow bilineage or trilineage dysplasia . | Cytogenetics clonal abnormality . | Final diagnosis . | Erythroid . | Megakaryocytic . | Myeloid . | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | |||||||||
| 1 | F | H | 34 | − | + | + | NE | RA | − (NE) | + | + | − | NE | + |
| 2 | F | W | 70 | + | + | + | + | RA | + | − | + | + | + | + |
| 3 | M | W | 60 | + | + | + | − | RA | + | + | + | − | + | + |
| 4 | M | B | 32 | − | + | + | − | RA | + | + | + | + | + | + |
| 5 | M | W | 65 | + | + | + | − | RA | + | + | + | − | − | + |
| 6 | F | W | 72 | − | + | + | + | RA | − | − | + | + | + | + |
| 7 | F | W | 46 | − | + | − | − | RA | + | − | + | − | + | + |
| 8 | M | W | 27 | + | + | + | NE | RA | + | + | + | + | + | + |
| 9 | F | A | 58 | + | + | NE | − | RA | + | + | + | − | + | NE |
| 10 | F | W | 62 | + | + | + | − | RA | + | + | − | − | + | + |
| 11 | M | A | 77 | − | + | + | + | RA | + | + | + | + | + | NE |
| 12 | M | W | 76 | + | + | + | − | RA | + | + | + | − | + | + |
| 13 | M | B | 61 | + | + | + | + | RA | + | + | + | − | + | + |
| 14 | F | W | 67 | + | + | + | + | RA | + | + | + | + | − | + |
| 15 | F | W | 49 | + | + | + | + | RA | − | + | + | + | + | + |
| 16 | M | W | 60 | − | + | + | + | RA | NE | + | + | + | − | + |
| 17 | M | W | 69 | + | + | + | − | RA | + | + | + | + | + | + |
| 18 | M | W | 47 | − | + | − | NE | RA | + | − | + | − | − | + |
| 19 | F | W | 37 | − | + | + | − | RA | + | + | + | NE | + | + |
| 20 | F | W | 43 | + | + | + | − | RA | − | + | + | + | + | + |
| 21 | M | W | 45 | + | + | − | − | RA | + | − | + | − | + | + |
| 22 | M | W | 56 | + | + | + | − | RA | − | + | + | + | + | + |
| 23 | M | W | 57 | + | + | + | − | RARS | + | + | + | + | + | + |
| 24 | M | W | 68 | + | + | + | NE | RARS | + | + | + | + | + | + |
| 25 | M | W | 72 | + | + | + | + | RARS | + | + | + | + | + | + |
| 26 | M | W | 60 | + | + | + | + | RARS | + | + | − | + | − | + |
| 27 | F | W | 66 | + | + | + | + | RARS | + | + | + | − | + | + |
| 28 | F | W | 44 | − | + | + | − | RARS | + | + | + | + | + | − |
| 29 | F | W | 67 | + | + | + | + | RARS | + | + | − | + | + | + |
| 30 | M | W | 61 | − | + | − | NE | RARS | + | − | + | − | NE | + |
| 31 | M | W | 67 | + | + | + | − | RARS | + | − | + | + | − | + |
| 32 | M | W | 69 | + | + | + | + | RARS | + | − | + | + | − | + |
| 33 | M | W | 63 | + | + | + | + | RAEB | − | + | + | + | + | + |
| 34 | M | W | 64 | − | + | NE | NE | RAEB | − | NE | − | − | + | + |
| 35 | F | W | 69 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 36 | F | W | 61 | + | + | + | − | RAEB | + | + | + | − | + | + |
| 37 | M | W | 65 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 38 | M | W | 58 | + | + | + | + | RAEB | + | + | + | − | + | + |
| 39 | M | W | 51 | − | + | − | − | RAEB | + | − | + | − | − | + |
| 40 | M | W | 81 | + | + | + | + | RAEB | + | + | + | + | + | NE |
| 41 | M | W | 71 | + | + | + | − | RAEB | − | − | + | + | + | + |
| 42 | F | W | 61 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 43 | M | W | 72 | + | + | + | + | RAEB | + | + | + | + | + | + |
| 44 | M | W | 64 | + | + | + | − | RAEB | + | + | + | − | + | + |
| 45 | F | W | 63 | + | + | + | + | RAEB-T | + | + | + | − | + | + |
BM indicates bone marrow; MDS, myelodysplastic syndrome; H, Hispanic; + or −, whether diagnostic criteria for MDS or dysplasia were met as described in “Patients, materials, and methods” and “Results”; NE, not evaluable; RA, refractory anemia; W, white; B, black; RARS, RA with ringed sideroblasts; RAEB, RA with excess blasts; RAEB-T, RAEB in transformation.